These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16039114)

  • 1. Endocrine late effects from multi-modality treatment of neuroblastoma.
    van Santen HM; de Kraker J; Vulsma T
    Eur J Cancer; 2005 Aug; 41(12):1767-74. PubMed ID: 16039114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.
    Clement SC; van Eck-Smit BL; van Trotsenburg AS; Kremer LC; Tytgat GA; van Santen HM
    Pediatr Blood Cancer; 2013 Nov; 60(11):1833-8. PubMed ID: 23832530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved radiation protection of the thyroid gland with thyroxine, methimazole, and potassium iodide during diagnostic and therapeutic use of radiolabeled metaiodobenzylguanidine in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2003 Jul; 98(2):389-96. PubMed ID: 12872361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [131I]MIBG as a first line treatment in advanced neuroblastoma.
    Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.
    Garaventa A; Gambini C; Villavecchia G; Di Cataldo A; Bertolazzi L; Pizzitola MR; De Bernardi B; Haupt R
    Cancer; 2003 Mar; 97(5):1332-8. PubMed ID: 12599242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients.
    Garaventa A; Bellagamba O; Lo Piccolo MS; Milanaccio C; Lanino E; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Claudiani F; De Bernardi B
    Br J Cancer; 1999 Dec; 81(8):1378-84. PubMed ID: 10604736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High incidence of thyroid dysfunction despite prophylaxis with potassium iodide during (131)I-meta-iodobenzylguanidine treatment in children with neuroblastoma.
    van Santen HM; de Kraker J; van Eck BL; de Vijlder JJ; Vulsma T
    Cancer; 2002 Apr; 94(7):2081-9. PubMed ID: 11932913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
    Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma.
    Matthay KK; Yanik G; Messina J; Quach A; Huberty J; Cheng SC; Veatch J; Goldsby R; Brophy P; Kersun LS; Hawkins RA; Maris JM
    J Clin Oncol; 2007 Mar; 25(9):1054-60. PubMed ID: 17369569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.
    Clement SC; van Rijn RR; van Eck-Smit BL; van Trotsenburg AS; Caron HN; Tytgat GA; van Santen HM
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):706-15. PubMed ID: 25512056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
    Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of chemotherapy and 131I-metaiodobenzylguanidine in the treatment of advanced-stage neuroblastoma.
    Sari O; Uğur O; Emir S; Akyüz C
    Turk J Pediatr; 2001; 43(1):29-33. PubMed ID: 11297155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [131I meta-iodobenzylguanidine in combination with hyperbaric oxygen therapy in the treatment of prognostically high-risk forms of neuroblastoma].
    Stanková J; Kavan P; Krízová H; Hermanská E; Dosel P; Sázel M
    Cas Lek Cesk; 2001 Jan; 140(1):13-7. PubMed ID: 11242978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Megatherapy combining I(131) metaiodobenzylguanidine and high-dose chemotherapy with haematopoietic progenitor cell rescue for neuroblastoma.
    Miano M; Garaventa A; Pizzitola MR; Piccolo MS; Dallorso S; Villavecchia GP; Bertolazzi C; Cabria M; De Bernardi B
    Bone Marrow Transplant; 2001 Mar; 27(6):571-4. PubMed ID: 11319584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age.
    de Kraker J; Hoefnagel KA; Verschuur AC; van Eck B; van Santen HM; Caron HN
    Eur J Cancer; 2008 Mar; 44(4):551-6. PubMed ID: 18267358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma.
    DuBois SG; Messina J; Maris JM; Huberty J; Glidden DV; Veatch J; Charron M; Hawkins R; Matthay KK
    J Clin Oncol; 2004 Jun; 22(12):2452-60. PubMed ID: 15197208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.
    Clement SC; Kraal KC; van Eck-Smit BL; van den Bos C; Kremer LC; Tytgat GA; van Santen HM
    J Clin Endocrinol Metab; 2014 Jan; 99(1):E112-6. PubMed ID: 24187404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy.
    Modak S; Pandit-Taskar N; Kushner BH; Kramer K; Smith-Jones P; Larson S; Cheung NK
    Pediatr Blood Cancer; 2008 Jun; 50(6):1271-3. PubMed ID: 17973318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a benefit of 131 I-MIBG therapy in the treatment of children with stage 4 neuroblastoma? A retrospective evaluation of The German Neuroblastoma Trial NB97 and implications for The German Neuroblastoma Trial NB2004.
    Schmidt M; Simon T; Hero B; Eschner W; Dietlein M; Sudbrock F; Bongartz R; Berthold F; Schicha H
    Nuklearmedizin; 2006; 45(4):145-51; quiz N39-40. PubMed ID: 16964339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.